Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery
Recruiting · NCT03349762 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →What this trial is about
To evaluate the efficacy and safety of Huaier granules for Prevention of Recurrence and Metastasis of colorectal cancer patients following radical surgery
Who can take part
Age range
18 Years to 75 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Males or females ages 18-75 years;
- The first time to the therapy of patients who received the radical surgery within two months, Postoperative histopathology confirms the diagnosis of colorectal cancer with stage IIB, IIC and III ( TNM classification)
- ECOG score of 0-2;
- No history of malignant tumors;
- The patients are volunteered for the study, sign informed consent form and cooperate with Investigator to collect data.
Exclusion criteria
- Patients have basic diseases including heart diseases, cerebrovascular disease, lung disease, severe hypertension or diabetes with poor glycemic control;
- confirmed infections after surgery ;
- Patients who have post-surgery complications or who are currently under the influence of the radical surgery for colorectal cancer;
- Being infected with syphilis or with other blood-borne infectious diseases;
- Pregnancy or lactation; or women of childbearing potential not using contraception;
- Patients who have taken Traditional Chinese Medicines with efficacy and indications similar to that of Huaier granule - including, but not limited to, compound Banmao capsule., Huachansu capsule, Kangai Injection and Pingxiao tablets;
- Patients who are suffering from mental illness or Conditions that are considered not suitable for this study investigators.
Where it is running
22 locations listed.
- Cancer Hospital Chinese Academy of Medical Sciences - Beijing, China
- Fudan University Shanghai Cancer Center - Shanghai, China
- The Fourth Hospital of Hebei Medical University - Shijiazhuang, Hebei, China
- The First Clinical Hospital affiliated to Harbin Medical University - Harbin, Heilongjiang, China
- The Second Affiliated Hospital of Harbin Medical University - Harbin, Heilongjiang, China
- Hubei Cancer Hospita - Wuhan, Hubei, China
- Union Hospital Tongji College Huazhong University of Science and Technology - Wuhan, Hubei, China
- Hunan Provincial People's Hospital - Changsha, Hunan, China
- Xiangya Hospital Central South University - Changsha, Hunan, China
- Changzhou No.2 People's Hospital - Changzhou, Jiangsu, China
- The Affiliated Hospital of Xuzhou Medical University - Xuzhou, Jiangsu, China
- Northern Jiangsu People's Hospital - Yangzhou, Jiangsu, China
- Anshan Cancer Hospital - Anshan, Liaoning, China
- Ansteel Group General Hospital - Anshan, Liaoning, China
- The First Affiliated Hospital of Jinzhou Medical University - Jinzhou, Liaoning, China
- Shandong Provincial Hospital - Jinan, Shandong, China
- The Affiliated Hospital of Qingdao University - Qingdao, Shandong, China
- Yantai Yuhuangding Hospital - Yantai, Shandong, China
- Zaozhuang Municipal Hospital - Zaozhuang, Shandong, China
- First Affiliated Hospital of Xi'an Jiaotong University - Xi’an, Shanxi, China
- Tianjin Medical University Cancer Institute and Hospital - Tianjin, Tianjin Municipality, China
- First Affiliated Hospital of Xinjiang Medical University - Ürümqi, Xinjiang, China